The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
Chris Dunphy, who stepped down last month, reckons most New Zealand companies have too many directors.
Shareholders also lodge large protest vote against chair’s re-election.
Forsyth Barr has upgraded its rating from underperform to neutral after a deep dive on the global anaesthesia market.
The group chief executive has written to shareholders about company's desire to leave the NZX for USX.
Sean Joyce-chaired Blackwell Global Holdings will rename as RTO Ltd after director arrested on 'unrelated' matters.
Airline says strong North American competition, weak domestic demand and high costs are cutting into its bottom line.
The initiative approved by shareholders aims to sure up fruit supply in a competitive market.
The newly-developed trading platform will plump up Sharesies' b2b revenue.
Chair John McMahon defends NZX's total shareholder returns as board seeks 38% pay rise.